Navigation Links
GlaxoSmithKline Wins Environmental Stewardship Award
Date:2/24/2011

NAPERVILLE, Ill., Feb. 24, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK), one of the world's leading pharmaceutical companies, has received the 2010 Environmental Stewardship Award from Nalco Company (NYSE: NLC) in recognition of GSK's ongoing efforts to reduce its climate change impact and energy and water use.

(Logo: http://photos.prnewswire.com/prnh/20101231/NALCOLOGO)

The Environmental Stewardship Award recognizes exceptional performance in achieving sustainability objectives and financial goals.  "The award targets global enterprises that set aggressive environmental commitments," said Emilio Tenuta, Nalco's Director of Sustainability.  "In addition, it recognizes companies that go beyond measuring performance and embrace a mindset of continuous improvement to help achieve or surpass their targets by leveraging the partnerships of experts in the industry."

In 2006, GSK set targets to reduce its water consumption by 2 percent per year by 2010.  By 2009, water consumption had been decreased 15 percent, significantly exceeding those goals.  In addition, in 2007 GSK launched a climate change program for its operations, setting targets to reduce energy use by 45 percent per unit of sales by 2015, using 2006 figures as a benchmark.  

Richard Pamenter, Vice President and Head of GSK's Environmental Sustainability Centre of Excellence said, "GSK is pleased to receive this award from Nalco as it reinforces our commitment to environmental sustainability, which is essential to our role as a good corporate citizen.  It makes business sense too.  If we continue to develop these relationships – with Nalco, for example – and establish others, we will continue to show how GSK is focused on doing the right thing."

The annual Environmental Return on Investment (eROI) that GSK has achieved from using Nalco's sustainable solutions includes:

  • more than 325,000 cubic meters (85.8 million gallons) of water savings, enough for the annual water needs of nearly 3,400 people,
  • 4.1 million kWh of energy savings, equal to 147 households annual use, and
  • 2,000 metric tonnes of CO2 reduction, equal to more than 83,000 trees.

These environmental improvements also resulted in financial savings for GSK of more than pounds Sterling 1.3 million since 2008.

The award selection committee included Nalco representatives and input from the Water Innovation Alliance (WIA).  

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information please visit www.gsk.com.

About Nalco

Nalco is the world's largest sustainability services company focused on industrial water, energy and air applications; delivering significant environmental, social and economic performance benefits to our customers.  We help our customers reduce energy, water and other natural resource consumption, enhance air quality, minimize environmental releases and improve productivity and end products while boosting the bottom line.  Together our comprehensive solutions contribute to the sustainable development of customer operations.  Nalco is a member of the Dow Jones Sustainability Indexes.  More than 12,000 Nalco employees operate in 150 countries supported by a comprehensive network of manufacturing facilities, sales offices and research centers to serve a broad range of end markets.  In 2010, Nalco achieved sales of $4.25 billion.  For more information, visit www.nalco.com.

Follow us on Twitter at www.twitter.com/Nalco_News and www.twitter.com/NalcoCompany.

About Water Innovations Alliance

The Water Innovations Alliance is an industry association focused on developing new funding, reducing regulatory barriers, increasing collaboration and raising awareness for cutting-edge water technologies and the problems they solve.  The Alliance serves the entire spectrum of the water sector: corporations, investors, engineering firms, start-ups, NGOs, research centers, municipalities, and others in the field.  It is a 501(c)(6) trade organization.  To learn more about the Alliance visit www.waterinnovations.org.


'/>"/>
SOURCE Nalco
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline 15th Annual IMPACT Awards Seek Philadelphia Area and Camden Healthcare Nonprofits
2. GlaxoSmithKline Applauds North Carolinas Child Advocates
3. A Statement from GlaxoSmithKline Consumer Healthcare on FDA Regulation of Smokeless Tobacco Products
4. Mylan Granted Temporary Restraining Order Against GlaxoSmithKline and Apotex Prohibiting the Supply, Sale and/or Importing of a Generic Version of Paxil CR
5. GlaxoSmithKline CEO Interviewed On Half-Year and Q2 Results
6. GlaxoSmithKline Statement in Response to FDA Advisory Committees Vote on Safety of Avandia® (rosiglitazone)
7. ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration
8. Johnson Controls Secures Global Facilities Management Win With GlaxoSmithKline
9. North Carolina GlaxoSmithKline Foundation Working With Nonprofits to Promote Health, Science and Education Through Ribbon of Hope Grants
10. Cellzome Announces Second Major Strategic Drug Discovery Alliance with GlaxoSmithKline in Inflammatory Disease
11. GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... -- According to a new market report published ... Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - ... valued at US$ 5.89 Bn in 2014 and is anticipated ... 2023 to reach US$ 7.99 Bn in 2023. ... free drug delivery devices and the market is estimated based ...
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of ... Tribute to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who ... this year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program ...
(Date:5/27/2016)... ... 27, 2016 , ... With over 60 percent of acute stroke survivors being ... product to aid in the rehabilitation process has steadily increased. Ekso Bionics had been ... hemiplegia due to stroke. , Ekso Bionics has now received clearance from the U.S. ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... help educate the many who are unaware of the plight of aphasia. In ... run within the “Stroke Awareness” campaign. , The link between stroke and aphasia ...
(Date:5/27/2016)... ... , ... Aimed at nurses and employees in the health care world, this ... the nursing and health care industry. It also provides insight to the developing trends ... , As the nursing industry is coming out of one of the biggest recessions ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
Breaking Medicine News(10 mins):